SLC7A5 and diffuse large B-cell lymphoma: Clinically, the majority of patients with DLBCL have a poor prognosis compared with patients with FL due to their aggressive tumor growth, and the mean LAT1 expression level was also high in DLBCL (80.1%) than in FL (24.9%).